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Abstract 
Objective: Salivary gland (SG) development is based on branching morphogenesis, in which 
programmed cell death has been proposed to play a role in cell signalling and organ shaping. 
In the mouse salivary gland apoptosis has been suggested to play a key role in lumen 
formation, removing the central cells of the epithelial stalks. Here we analyse the expression 
of several anti- and pro-regulators of apoptosis during human SG development in a range of 
developmental stages.  
Design: Foetal SGs obtained from the University of São Paulo were analysed by 
immunohistochemistry to assess the expression of apoptosis-associated proteins: caspases 
(caspase-6, -7, -9 and cleaved caspase-3), Bcl-2 family members (Bax, Bak, Bad, Bid, Bcl-2, 
Bcl-x and Bcl-xL), Survivin (BIRC5), Cytochrome C and Apaf-1.  
Results: Nuclear expression of Bax and Bak was identified in presumptive luminal areas at 
initial stages, while Bcl-xL showed the most relevant anti-apoptotic activity. Caspase-6, -7 
and -9 were expressed during all stages, while interestingly cleaved caspase-3 showed no 
prominent expression, indicating that caspase-7 is the main effector. Apoptosome complex 
components Apaf-1 and Cytochrome C, as well as survivin were all positive in developing 
glands.  
Conclusions: The particular expression pattern of several apoptotic regulators in human SG 
development suggests the existence of a fundamental role for apoptosis during duct 
formation. The absence of Bad and Bid expressions indicates that the instrinsic pathway is 
more active then the extrinsic during human gland formation. The subcellular localisation of 
intrinsic-apoptosis proteins correlated with apoptotic activity, but also suggested additional 
non-apoptotic functions. 
  
Highlights: 
 Caspase-7 is the main executioner caspase involved in human SG duct development 
 Consistent cytoplasmic expression suggest additional non-apoptotic functions  
 Intrinsic-type apoptotic pathway drives human SG development 
  
Introduction  
The development of functionally complex and well-ordered salivary glands (SG) 
requires epithelial-mesenchymal interaction that depends on a variety of cellular signalling, 
growth factors and associated extracellular matrix components (Harunaga, Hsu, & Yamada, 
2011; Patel, Rebustini, & Hoffman, 2006). SG development has classically been divided into 
five embryonic stages, well described as prebud, initial bud, pseudoglandular, canalicular (or 
cavitation), and terminal bud, observed in both mouse and human development (Melnick & 
Jaskoll, 2000; Teshima et al., 2011; Tucker, 2007). Apoptosis is a type of programmed cell 
death, which has been shown to be very important for the regulation of developmental and 
pathological processes (Elmore, 2007). Its role in gland morphogenesis is associated with the 
elimination of the central cells within solid epithelial stalks in order to create lumens (Andrew 
& Ewald, 2010; Debnath et al., 2002; Mailleux et al., 2007; Melnick & Jaskoll, 2000; Wells 
& Patel, 2010). In keeping with this, inhibition of apoptosis during mouse SG development in 
vitro has recently been shown to impair lumen formation (Teshima et al., 2016). Despite this 
knowledge from studies in the mouse, a comprehensive analysis of the expression of 
apoptosis regulators in human glands has not been previously carried out.  
Different molecular pathways can trigger the complex apoptosis cascade (Suzanne & 
Steller, 2013). The extrinsic pathway (death-receptor pathway) involves transmembrane 
interactions mediated by apoptotic signalling from neighbouring cells that signal through 
receptors from the tumour necrosis factor superfamily (TNFr)(3). The intrinsic pathway in 
contrast does not depend on extracellular regulators, although sometimes a crosstalk can 
occur between them by Bid and caspase-8 (Korsmeyer et al., 2000; H. Li, Zhu, Xu, & Yuan, 
1998). Diverse intracellular stress such as DNA damage, hypoxia, oncogene activation and 
deprivation of growth factors can activate this pathway, and mitochondria is the central 
organelle involved, acting through the release of several pro-apoptotic molecules into the 
cytoplasm (Danial & Korsmeyer, 2004). 
The intrinsic apoptotic pathway is mainly triggered by Bcl-2 (B cell lymphoma 2) 
family proteins; the balance between pro and anti-regulators defines cell fate (Chipuk, 
Moldoveanu, Llambi, Parsons, & Green, 2010; Elmore, 2007; Martinou & Youle, 2011). Bax 
and Bak proteins are the main pro-apoptotic members that essentially modify the 
mitochondrial membrane permeability. Upon activation by endogenous death signals, Bax 
and Bak undergo oligomerization and promote the release of contents of the mitochondrial 
intermembrane space such as cytochrome c, at which point the apoptotic cascade is 
irreversibly activated (Karbowski, Norris, Cleland, Jeong, & Youle, 2006; Wei et al., 2001). 
Once released, cytochrome c binds to Apaf-1 (apoptotic protease activating factor 1) and 
caspase-9 to form the apoptosome complex, which then activates the caspase-dependent 
apoptotic cascade (Kuida et al., 1998; Riedl & Salvesen, 2007; Yoshida et al., 1998). 
Antagonising the pro-apoptotic function, several Bcl-2 family members as Bcl-2, Bcl-x, Bcl-
w, Mcl-1, A1 and Bcl-xL inhibit cell death by preventing the permeabilisation of the 
mitochondrial membrane. These family members also represent an important survival factor 
for cancer progression and resistance to anticancer therapies especially when overexpressed 
(Cory & Adams, 2002). Bcl-2 and Bcl-xL serve a principal role of binding and sequestering 
specific anti-survival Bcl-2 family proteins (BH3-only molecules) that prevents Bax and Bak 
activation, while Bcl-xL and Mcl-1 seem to be the key direct antagonists of Bak (Willis et al., 
2005).  
Cystein proteinases, known as caspases, are also required for apoptosis-related 
events, being considered essential regulators of cell death and inflammation. Mammalian 
caspases-2, -3, -6, -7, -8, -9 and -10 represent apoptotic caspases based on their function and 
they are classified into initiator and executioner members. External death receptors and cell 
intrinsic signals can both stimulate the apoptosis machinery by irreversibly activating 
upstream caspases (-2, -8, -9, -10) and consequently the effector members (-3, -6, -7) 
(Elmore, 2007; Slee, Adrain, & Martin, 1999). Recently, non-apoptotic roles have also been 
attributed to apoptosis-associated caspases that determine cell differentiation, embryonic 
development, cell signalling, motility and compensatory proliferation (Connolly, Jäger, & 
Fearnhead, 2014; Kuranaga, 2012; Leist & Jäättelä, 2001; Shalini, Dorstyn, Dawar, & Kumar, 
2014). 
It has been shown that certain apoptotic regulators are critical for normal 
embryogenesis as seen in digit and mammary gland formation (Meier, Finch, & Evan, 2000). 
Given the recent research showing additional non-apoptotic functions for cell death signalling 
during development, this study has focused on analysing the expression pattern of several 
apoptosis-related proteins in human SG formation, with the aim of understanding what 
pathways might be involved during gland development. 
Material and Methods 
 Tissue preparation: Major and minor salivary glands from 70 post-mortem human 
foetuses from natural miscarriages at 4-24 prenatal weeks were obtained from the Medical 
School of the University of São Paulo under approval of the local Ethical Committee and of 
the Dental School of the same institution. Foetal SGs were then histologically processed, 
paraffin-embedded, serial-sectioned and stained with haematoxylin and eosin to study their 
morphology. Selected specimens (N=15 each; major glands = parotid and submandibular; 
minor glands = palate and mouth floor) were then utilised for immunohistochemistry, to 
investigate the expression of Bcl-2, Bax, Bak, Bcl-x, Bcl-xL, Bad, Bid, caspases -6, -7 and -9, 
cleaved caspase-3, survivin, cytochrome c and Apaf-1, and each protein expression was 
analysed according to the developmental stages.  
Immunohistochemistry: Developing salivary gland samples were sectioned at 4m 
and serial sections were deparaffinised, re-hydrated and then submitted to antigen retrieval, as 
described in Table 1. Each antibody was investigated on all 15 samples, and the reactions 
were performed in triplicates to verify the reproducibility of the results. The sections were 
then incubated in 3% aqueous hydrogen peroxide for 15min to quench endogenous 
peroxidase activity, followed by Protein Block Serum-Free incubation (DakoCytomation, 
Carpinteria, CA, USA) for 20 min at room temperature to suppress non-specific binding of 
subsequent reagents. Primary antibodies were added for 2 hours at room temperature (clones, 
antibody sources and titles in Table 1) and the antigen-antibody complexes were visualized 
using Advance system (DakoCytomation, Carpinteria, CA, USA) followed by incubation 
with 3’3 diaminobenzidine tetrachloride (DAB) (DakoCytomation, Carpinteria, CA, USA) for 
5min. Sections were then counterstained with Mayer’s haematoxylin, dehydrated and 
mounted with glass coverslip and xylene based mountant. All immunohistochemical assays 
and analysis were carried out in duplicate. Negative controls were performed by incubation of 
the specimens with non-immune serum while positive controls were employed according to 
the manufacture recommendation. Blind qualitative evaluation of all protein expressions was 
performed by two experts in SG development using a conventional optical microscope 
(Olympus E330). 
 
Results  
 In order to assess the activity of the intrinsic apoptotic pathway during human SG 
development, the expression of key proteins involved in this process were investigated. This 
study included pro- and anti-apoptotic members of the Bcl-2 family, effectors and initiator 
caspases, apoptosome complex components and the apoptotic inhibitor survivin. All results 
were scored in a semi-qualitative analysis summarised in Tables 2, 3 and 4, which describe 
the subcellular localisation of each protein according to the developmental stage of the human 
SGs. It is worth noting that human SG formation is very heterogeneous and consists of mixed 
stages from early gestational age. Therefore this study focused on characterising and scoring 
each protein expression pattern according to developmental stages rather than type of gland or 
gestational age. Representative images of selective groups of proteins are shown in Figures 2 
to 5.  
Morphological comparison between mouse and human SG developmental stages can 
be visualised in Figure 1, showing the similarity of the gland initiation and branching 
morphogenesis. During development formation of the first epithelial bud results from an 
invagination of the oral epithelium (OE) towards the underlying mesenchyme (Fig 1A, 1F, 
1G, arrows). As proliferation continues, these epithelial buds progressively elongate and start 
forming long stalks at the pseudoglandular stage, where the gland starts to branch and the 
lumen space starts to form (Fig 1B, 1H, 1I, arrows). This is followed by the cavitation stage, 
where the glands are more branched and the ducts well luminised (Fig 1C, 1J, 1K, arrows). 
Finally the glands undergo differentiation, displaying acinar secretory units (Fig 1D, 1L, 1M, 
1E, 1N, arrowheads) and the presence of multi-layered excretory ducts (Fig 1O) at the 
terminal bud stage.  
We first investigated the expression of the pro-apoptotic proteins Bak, Bax, Bad and 
Bid, and anti-apoptotic regulators Bcl-2, Bcl-x and Bcl-xL represented the Bcl-2 family 
members. Semi-qualitative results according to each developmental stage are summarised in 
Table 2 and the expression patterns of all positive Bcl-2 family members during human SG 
development are illustrated in Figure 2. Bcl-2 was completely negative in all specimens, 
while Bad and Bid showed positivity in one isolated case (N = 1/15). Pro-apoptotic proteins 
Bax and Bak and apoptotic antagonists Bcl-x and Bcl-xL were observed during all 
developmental stages (Fig 2). Although Bax was mainly cytoplasmic in all ductal structures 
(Fig 2A to 2E), few central cells had Bax localised to their nuclear compartment within the 
presumptive lumen area of the ducts (Fig 2B, 2C, arrows). Detail of both subcellular 
localisations is illustrated in Fig 2E, where some central ductal cells showed nuclear 
expression (arrows). Bak in contrast revealed strong nuclear positivity within the presumptive 
ducts (Fig 2F, 2G, 2H, arrows), and cytoplasmic expression was exclusive at the terminal bud 
stage (Fig 2I). Both pro-apoptotic markers exhibited strong expression in the cytoplasm of 
collecting duct cells (Fig 5A, 5B, arrowheads), although Bax was also observed in the nucleus 
(Fig 5B, arrow). 
 Antagonistic regulators of intrinsic apoptosis Bcl-x and Bcl-xL were also observed 
during human SG development, however these two proteins showed opposite expression 
patterns. Bcl-x had its expression mainly concentrated within the cytoplasmic regions of 
ductal cells at all developmental stages (Fig 2K to 2O) with occasional nuclear positivity 
neighbouring the luminal area (Fig 2L, 2M, arrows). At the terminal bud stage the 
cytoplasmic expression of Bcl-x was more evident in the luminal epithelial layer of more 
developed ducts (Fig 2N, arrowhead) while small ducts near the acini exhibited discrete 
nuclear staining (Fig 2N, 2O, arrow). In contrast, Bcl-xL demonstrated more evident nuclear 
expression within the presumptive luminal areas (Fig 2N, 2O, arrows) with weak cytoplasmic 
positivity at the initial stage (Fig 2P) and complete absence within intercalated and striated 
ducts at terminal bud stage (Fig 2S). In collecting ducts, however, it was strongly expressed 
mainly in the nuclei (Fig 5D). 
 Caspases-3, -6 and -7 were included in this study as representing the most important 
effector caspases of the apoptotic pathway, while caspase-9 denoted the initiator protease. 
Semi-qualitative analysis of the results obtained was correlated according to SG 
developmental stages in Table 3. Caspase-3 protein expression was assessed in its activated 
form as a standard hallmark for detecting active apoptosis. Interestingly, cleaved caspase-3 
was completely negative in our analysis (Fig 3A to 3D). Initiator caspase-9 and effector 
caspases-6 and -7 in contrast were detected during almost all stages (Fig 3).  
Analysis of caspases-6 expression showed nuclear localisation from bud to 
canalicular stage within the presumptive lumen areas (Fig 3E to 3I). At the terminal bud 
stage, cytoplasmic expression became more prominent within intercalated ducts (Fig 3H, 
arrowhead), while caspase-6 remained mainly nuclear in striated and collecting ducts (Fig 3H, 
arrow, Fig 5E). Effector caspase-7 showed more pronounced nuclear than cytoplasmic 
expression (Fig 3J to 3N), particularly at the pseudoglandular stage (Fig 3K, arrow). More 
developed ducts also showed caspase-7 mainly within nuclear compartments (Fig 5F, arrow). 
Characteristic apoptotic nuclei were detected in association with nuclear caspase-7 in few 
samples (Fig 3N, arrow). Similar to caspase-6, initiator caspase-9 was present only in the 
nuclei of ductal cells at initial stages (Fig 3O, 3P). Subtle and localised cytoplasmic 
expression was observed at the canalicular stage (Fig 3Q) and within intercalated ductal cells 
at the terminal bud stage (Fig 3R, arrowhead). The prevalent nuclear expression of caspase-9 
remained stronger in collecting ducts (Fig 5G). 
  As part of the apoptosome complex, the expression of cytochrome c and Apaf-1 
through SG development were analysed and summarised in Table 4. Apaf-1 expression was 
more prevalent in the nuclei of ductal cells at all developmental stages (Fig 4A to 4D), being 
only observed in the cytoplasm within intercalated ductal cells at terminal bud stage (Fig 4D, 
arrowhead). Collecting ducts also showed more nuclear Apaf-1 (Fig 5H, arrow). In contrast, 
cytochrome c was exclusively cytoplasmic (Fig 4F to 4I), becoming stronger from the 
pseudoglandular stage. Same expression patter could be observed in developed collecting 
ducts (Fig 5I).  
The apoptotic inhibitor survivin showed well-defined subcellular expression patterns 
depending on the developmental gland stage, also described in Table 4. Early developing 
epithelial buds and stalks showed the predominance of cytoplasmic survivin (Fig 4K, 4L, 
arrowheads), in contrast to the later stages where nuclear expression is more evident (Fig 4M, 
4N, arrows). As more developed structures, collecting ducts also showed a nuclear-dominant 
positivity for survivin (Fig 5J).  
  
Discussion  
The correct regulation of programmed cell death is critical for developmental homeostasis 
and normal morphogenesis of embryonic tissues (Flusberg & Sorger, 2015). Apoptosis can be 
triggered by intrinsic and extrinsic factors, the intrinsic pathway involving mitochondrial 
events driven by Bcl-2 family proteins (Ulukaya, Acilan, & Yilmaz, 2011). In mouse SG 
formation, apoptosis has been proposed to be important for the removal of central ductal cells 
in order to originate the lumen space in a process called cavitation (Andrew & Ewald, 2010; 
Jaskoll, Chen, Min Zhou, Wu, & Melnick, 2001; Melnick & Jaskoll, 2000). This is strongly 
supported by recent in vitro studies where inhibition of caspases prevented duct narrowing 
and resulted in impaired branching morphogenesis (Teshima et al., 2016). 
The developmental pattern of human SGs has already been described as following a 
similar process compared to the mouse (Lourenço, Uyekita, Lima, & Soares, 2008; Teshima 
et al., 2011), although little is known about the role of apoptosis during human glandular 
morphogenesis. The expression of apoptosis-related proteins analysed in this study support a 
role for programmed cell death in gland development, particularly during lumen formation 
agreeing with recent research from the mouse (Teshima et al., 2016), however in the human 
samples apoptosis did not appear to involve the cleavage of the well-known downstream 
apoptotic regulator caspase-3.  
Bcl-2 family proteins are well known as key initiators of the apoptotic cascade 
(Moldoveanu, Follis, Kriwacki, & Green, 2014), and a balance between anti- and pro-
apoptotic members determines cell fate (Flusberg & Sorger, 2015), contributing to normal 
development and organ shape as shown in several in vivo models. Complete absence of both 
pro-apoptotic proteins Bax and Bak results in either prenatal lethality or severe defects in 
several tissues after birth (Lindsten et al., 2000). In the absence of Bax, Bak appears to 
compensate for the loss of Bax, perhaps explaining the lack of lumen phenotype published in 
Bax mutants (Nedvetsky et al., 2014). Due to compensation it is very difficult to make claims 
about the role of apoptosis from the phenotype of single knockouts. Lack of anti-apoptotic 
factors results in immunodeficiency and renal developmental problems in Bcl-2
-/-
 mice, 
whereas extensive apoptosis is observed within the liver and hematopoietic systems of Bcl-xL 
deficient mice (Hakem et al., 1998; Motoyama et al., 1995). Our results particularly showed 
varied nuclear and cytoplasmic expression of Bax, Bak, Bcl-x and Bcl-xL proteins in human 
developing SGs, specifically in ductal cells. Although the majority of apoptotic events occur 
in the cytosol, the nuclear localisation of several apoptotic markers has already been reported 
in mouse embryo cells and tumor cells, mostly associated with active apoptosis. Studies with 
immunohistochemistry and electron microscopy revealed prominent nuclear Bax expression 
in human colon adenocarcinoma where its expression increased after apoptotic stimulation 
over a short time frame (Gajkowska, Motyl, Olszewska-Badarczuk, & Godlewski, 2001). 
Similar findings were observed in other tumour cells (Wang, Ding, Chew-Cheng, Yun, & 
Chew, 1999) in which Bax and Bcl-2 proteins were detected in association with the nuclear 
matrix. Bax translocation to the nuclear envelope and through nucleus fibrous nucleoplasm 
was also shown in mouse mammary cells, increasing nuclear and mitochondrial Bax levels 
after TGF-beta1 apoptotic stimulation (Motyl et al., 2000). The nuclear localisation of these 
proteins in correlation with their apoptotic activity supports our findings, where prominent 
nuclear expressions of Bax, Bak and Bcl-xL were particularly found in presumptive duct 
areas, agreeing with the hypothesis that apoptosis regulates SG luminal opening. The pro-
apoptotic activity in lumen formation seems to be mainly associated with Bak control due to 
its more pronounced nuclear localisation compared to Bax, whereas Bcl-xL modulates 
apoptosis during initial lumen opening and Bcl-x takes place only at the latest stage.  
The Bcl-2 homologue pro-apoptotic proteins, Bad and Bid, induce apoptosis by extrinsic 
activation from the cytoplasmic membrane. They transmit cell death signalling through 
caspase-8 (H. Li et al., 1998; Luo, Budihardjo, Zou, Slaughter, & Wang, 1998). Their absence 
in our specimens strongly suggests that the apoptotic activation in human gland development 
depends only on cell intrinsic signalling, confirmed by prominent Bax and Bak expressions 
during all stages. Bid-deficient mice are also resistant to Fas-induced hepatocellular 
apoptosis, although intrinsic stimulation was not shown to result in abnormality, supporting 
the requirement for Bid in apoptosis only through extrinsic stimuli (Yin et al., 1999). 
Similarly, double Bax and Bak deficient mice illustrated resistance to both external (such as 
Fas-induced apoptosis and tBID-induced apoptosis) and intrinsic stimuli (such as growth 
factor deprivation and ultraviolet radiation), evidencing their requirement to activate both 
apoptotic pathways (Wei et al., 2001). Bad and Bid although negative in the majority of 
samples did show positivity in one foetal SG. Our samples were obtained from natural 
miscarriages and it is possible that this sample had activated the extrinsic pathway for an 
unknown reason, such as deprivation of nutrition. 
Caspases are considered essential apoptotic regulators of both apoptotic pathways and 
they are found in latent form in different subcellular compartments, being activated by 
distinct mechanisms such as proteolysis, oligomerisation or binding to membrane receptors or 
regulating factors (Hyman & Yuan, 2012; Ramuz et al., 2003). Specific subcellular 
localisation of caspases implies distinct roles during development according to the cell type.  
Nuclear expression of executioner caspase-7 has been reported to indicate active apoptotic 
functions during osteogenesis of tooth and jaw development and within the primary enamel 
knot (Leist & Jäättelä, 2001; Matalova, Svandova, & Tucker, 2012; Matalova, Vanden 
Berghe, et al., 2012; Miura, 2012; Svandova et al., 2014). Similarly, our results demonstrated 
prevalent nuclear caspase-7 expression during ductal formation, especially near presumptive 
lumenal areas. Moreover caspase-7 was observed within the characteristic apoptotic 
condensed nuclei (picnotic nuclei) in the central lumen area, suggesting apoptotic activity in 
these regions. As an executioner member in the caspase machinery, it is considered that 
caspase-7 shares properties with caspase-3 as shown in in vivo models where development 
was only impaired in double knockout mice, while the presence of caspase-7 compensates the 
lack of caspase-3 in single knockout (Lakhani et al., 2006). In addition, analysis of caspase-3 
deficient mice illustrates that components of the death pathway act in a tissue/cell type-
specific and stimulus-specific manner (Woo et al., 1998). Detection of cleaved caspase-3 is 
currently the apoptotic activation hallmark, although alternative caspase-independent cell 
death pathways have been reported (Leist & Jäättelä, 2001). Our data suggests that caspase-3 
might not be an accurate marker to identify apoptotic activity on its own. Negative expression 
of cleaved caspase-3 revealed in our study indicates therefore that caspase-7 is the main 
effector caspase in human SG development in contrast to previous reports in mouse models 
(Jaskoll et al., 2001).  
Unlike caspase-3 and -7, caspase-9 is an upstream regulator that comprises part of the 
apoptosome complex with Apaf-1 and cytochrome c proteins. Caspase-9 therefore represents 
an important intrinsic apoptotic receptor (Riedl & Salvesen, 2007). Previous findings have 
shown the requirement of caspase and Apaf-1 in embryogenesis, illustrating that their 
deficiency promotes defects in mouse olfactory and neural development correlated with 
apoptotic and non-apoptotic functions (Ohsawa et al., 2010). The absence of initiator caspase-
9 displayed analogous but more severe in vivo effects than executioner caspase-3 in brain 
development (Hakem et al., 1998; Kuida et al., 1998). Additionally, mice lacking cytochrome 
c have also shown developmental defects in apoptosis, being more sensitive to intrinsic and 
extrinsic cell death signals (Li et al., 2000). 
Subcellular localisation of caspase-9 was previously described in mammary epithelial 
cells, which suggested the epithelium specificity of this protein and associated its nuclear 
expression with intrinsic apoptotic activation (Ritter et al., 2000). Other studies with breast 
cell cultures also reported caspase-9 translocation upon cell stress-induced apoptosis in order 
to disassembly the nuclear-cytoplasmic barrier that allows caspase-3 function. Importantly, 
activation of caspase-9 was required for caspase-3 to enter the nucleus, whereas the nuclear 
translocation of caspase-9 did not require activation of caspase-3 (Faleiro & Lazebnik, 2000). 
Our data comparing nuclear and cytoplasmic expression agrees with these findings from 
mammary glands, particularly the finding that caspase-9 can be translocated to the nucleus in 
the absence of any caspase-3. 
 Given that Apaf-1 is part of the apoptosome complex with caspase-9, Apaf-1 has been 
shown to be redistributed to the nucleus during intrinsic-induced apoptosis in fibroblasts 
(Ruiz-Vela, Gonz lez de Buitrago,   Mart  nez-A, 2002). In contrast a diffuse cytochrome c 
was observed in the cytoplasm (Ruiz-Vela et al., 2002). A similar nuclear and cellular 
localisation of the apoptosome complex members was identified in our study, which may 
represent an early apoptotic hallmark in human SG development.  
Additional roles for caspases have recently been suggested, regulating compensatory 
proliferation of neighbouring cells, cell-fate determination, stem cell maintenance, tissue 
regeneration, actin-skeleton reorganisation determining cell shape, immune system and 
promotion of different types of programmed cell death (Abraham & Shaham, 2004; 
Kuranaga, 2011). Prominent cytoplasmic expression of caspases-6, -7 and -9 in human glands 
indicates the existence of potential non-apoptotic roles of these caspases at certain 
developmental stages. Expression of the effectors caspase-6 and -7 indicated complementary 
functions during human SG development, as caspase-6 expression was mainly concentrated 
within more developed ducts at later stage terminal bud, while caspase-7 was more evident at 
earlier stages.  
Apoptosis can also be controlled by several endogenous caspase inhibitors part of the 
inhibitors of apoptosis proteins (IAP) family. Survivin is the smallest member of the IAP 
family and is also known as baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5). It 
is abundantly expressed in foetal development and tumour cells in humans, while rarely 
present in differentiated tissues. The main role of survivin is to control apoptosis by inhibiting 
Bax and the extrinsic Fas pathways and binding to caspase-3 and -7, although additional roles 
in cell division have been described (Chi et al., 2014; Salvesen & Walsh, 2014). Survivin 
expression has been reported during mouse embryonic submandibular gland development 
flanking the lumen forming regions (Jaskoll et al., 2001). Given that survivin has both pro and 
anti-survival functions, they suggested that nuclear survivin played a role in anti-apoptotic 
activity, where it translocates to form the Cdk4/survivin complex. Survivin expression was 
quantitative and qualitatively higher at later stages, indicating it is a key survival factor of 
epithelial cells surrounding forming ducts and terminal bud lumina (Jaskoll et al., 2001). Our 
results in human glands similarly showed prevalent nuclear localisation of survivin at later 
stages, where apoptosis in the ducts seems to be more controlled once the lumen space has 
already formed.   
This work has evidenced the protein expression profile of several apoptosis-related 
regulators during human salivary gland morphogenesis, supporting that apoptosis is important 
for SG lumen formation (Melnick & Jaskoll, 2000) however these molecules are also likely to 
have other non-apoptotic functions within the gland (Fan & Bergmann, 2008). Emerging 
research in developmental biology is revealing new insights into salivary gland formation, 
especially with the advantage of more transgenic lines available, indicating indeed new 
perspectives of apoptotic roles in development. Distinct localisation of several apoptotic 
regulators may extend their potential sites of action and collaborate in additional roles 
essential for normal development but also for tumour progression. Hence revealing specific 
biological processes in SG morphogenesis may help to define novel targets and activation 
pathways, uncovering markers and treatments for salivary gland dysfunction and disease. 
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Tables 
 
Primary serum Clones Title Source Antigen Retrieval 
Bak Polyclonal 1:300 Dako 
Citrate buffer, pH 
6.0 
Bax Polyclonal 1:400 Dako 
Citrate buffer, pH 
6.0 
Bad (N-term) Y208 1:500 Epitomics EDTA, pH 9.0 
Bid BH3 1:100 Epitomics 
Citrate buffer, pH 
6.0 
Bcl-2 124 1:200 Dako 
Citrate buffer, pH 
6.0 
Bcl-xL 7D9 1:2000 Chemicon 
Citrate buffer, pH 
6.0 
Bcl-x Polyclonal 1:500 Dako 
Citrate buffer, pH 
6.0 
Cleaved caspase-3 Polyclonal 1:600 Cell Signaling 
Citrate buffer, pH 
6.0 
Caspase-6 (C-term) E180 1:150 Epitomics EDTA, pH 9.0 
Caspase-7 7CSP01 1:150 Chemicon 
Citrate buffer, pH 
6.0 
Caspase-9p10 H83 1:500 Santa Cruz 
Citrate buffer, pH 
6.0 
Apaf-1 Polyclonal 1:30 Novocastra 
Citrate buffer, pH 
6.0 
Cytochrome C CTC05 1:3000 Chemicon 
Citrate buffer, pH 
6.0 
Survivin Polyclonal 1:400 Neomarkers EDTA, pH 9.0 
 
Table 1. Summary of respective primary antibody sources, clones, titles and antigen retrieval method 
included in this study.  
  
 
Pro-apoptotic Anti-apoptotic 
Bax Bak Bid 
 
Bcl-x Bcl-xL Bcl-2 
 C N C N C N  C N C N C N 
Initial Bud + ++ ++ + 0 0 
 
++ + + + 0 0 
Pseudoglandular ++ + ++ + 0 0 
 
++ + 0 + 0 0 
Canalicular ++ + ++ + 0 0 
 
++ + 0 ++ 0 0 
Terminal Bud 
Collecting ducts 
Small ducts 
 
++ 
+ 
 
+ 
0 
 
+ 
+ 
 
0 
+ 
 
0 
0 
 
0 
0 
 
 
++ 
+ 
 
+ 
+ 
 
+ 
0 
 
++ 
0 
 
0 
0 
 
0 
0 
 
Table 2. Semi-qualitative analysis of anti and pro-apoptotic Bcl-2 family proteins expression pattern in 
human salivary gland development, according to each morphogenetic stage. Cytoplasmic (C) and 
nuclear (N) expressions are shown separately. ++ = strong expression; + = weak expression; 0 = no 
expression. Small ducts = striated and intercalated ducts. 
  
 Table 3. Semi-qualitative analysis of caspase expression pattern in human salivary gland development. 
Cytoplasmic (C) and nuclear (N) expressions are shown separately. ++ = strong expression; + = weak 
expression; 0 = no expression. Small ducts = striated and intercalated ducts. 
  
 
Initiator  Executioners 
Caspase-9  Caspase-6 Caspase-7 Cl. Caspase-3 
 C N  C N C N C N 
Initial Bud 0 +  0 + + + 0 0 
Pseudoglandular 0 +  0 + + ++ 0 0 
Canalicular + ++  0 + + + 0 0 
Terminal Bud 
Collecting ducts 
Small ducts 
 
+ 
+ 
 
++ 
+ 
 
 
+ 
+ 
 
++ 
+ 
 
0 
+ 
 
+ 
0 
 
0 
0 
 
0 
0 
 
Table 4. Semi-qualitative analysis of Survivin, Apaf-1 and Cytochrome C expression patterns during 
human SG development. Cytoplasmic (C) and nuclear (N) expressions are shown separately. ++ = 
strong expression; + = weak expression; 0 = no expression. Small ducts = striated and intercalated 
ducts. 
A 
IAP  Apoptosome 
Survivin  Apaf-1 Cytochrome C 
 C N  C N C N 
Initial Bud ++ +  0 ++ + 0 
Pseudoglandular ++ +  + ++ ++ 0 
Canalicular + ++  + + ++ 0 
Terminal Bud 
Collecting ducts 
Small ducts 
 
0 
0 
 
++ 
++ 
 
 
++ 
+ 
 
++ 
+ 
 
+ 
0 
 
0 
0 
Figure legends: 
Figure 1: Comparative images between mouse and human developmental stages of SG 
morphogenesis 
(A-E) Mouse SG development.  
(F-O) Human SG development.  
(A, F, G) Bud stage showing initial growth of the oral epithelium (OE) towards the 
underlying mesenchyme, forming the first epithelial bud (arrows).  
(B, H, I) Pseudoglandular stage showing the beginning of lumen formation with in the 
epithelial stalks (arrows), and the start of branching morphogenesis.  
(C, J, K) More branched epithelial structures at the canalicular stage exhibiting multiple 
ducts with well defined lumal spaces (C, K, arrows).  
(D, E, L, M, N, O) Terminal bud stage presents extensive ducts associated with differentiated 
secretory units (E, N, arrowhead) that show wide and bright cytoplasm with pyramidal 
morphology (L, M, N, arrowheads). Luminised excretory duct with multiple epithelial layers 
at the final stage (O). Histological stainings with hemaetoxylin and eosin (A-D, F-O) 
and Masson’s trichrome (E). Magnifications: E = 40X; A, B, C, D = 100X; J, L = 
200X; F, G, H, I, K, M, N, O = 400X. Scale bars = 100µm. 
 
Figure 2: Anti-apoptotic Bcl-xL modulates Bax and Bak activity in human SG 
development 
(A, B, C, D) Bax expression; during early development, nuclear localisation is more 
prominent in presumptive ductal regions (A, B, C, arrows) while cytoplasmic staining is 
prevalent at late stage (D) (A, B, C = parotid glands; D = mouth floor minor glands).   
(F, G, H, I) Bak expression; evidence of apoptotic activity within ductal structures in 
expected lumen space area (F, G, arrows) and scarce nuclear expression detected at the 
terminal bud stage (H) (F, H = parotid glands; G = submandibular gland; I = palatal gland). 
(K, L, M, N) Bcl-x expression was mainly cytoplasmic in all developmental stages, 
occasionally present in the nucleus of epithelial cells near lumen regions (J, K, arrows) (K, L, 
M = submandibular gland; N = mouth floor).  
(P, Q, R, S) Bcl-xL expression shows important nuclear positivity in presumptive lumen 
areas, especially at pseudoglandular and canalicular stages (N, O, arrows), being completely 
absent at the latest stage (S) (P, R = parotid glands; Q = submandibular gland; S = palatal 
glands).  
(E, J, O, T) High power of nuclear (arrows) and cytoplasmic (arrowheads) expressions of 
Bax (E, parotid gland), Bak (J, parotid gland), Bcl-x (O, submandibular gland) e Bcl-xL (T, 
parotid gland) within developing ducts. Arrows represent nuclear positivity, arrowheads 
indicate cytoplasmic expression. Magnifications: A-D, F-I, K-N, P-S = 400X; E, J, O, T = 
1260X (zoom). Scale bars = 30µm.  
 
Figure 3: Caspase expression profile in human gland development 
(A, B, C, D) Cleaved Caspase-3 was negative in all specimens analysed (A, B = 
submandibular glands; C = parotid gland; D = mouth floor gland).  
(E, F, G, H, I) Caspase-6 expression; only nuclear positivity is observed within epithelial 
stalks during early stages (E, F, arrows), while late stages canalicular and terminal bud 
showed balanced expression between nucleus and cytoplasm within all ductal network (G, 
H, arrows and arrowheads). Nuclear expression at early stages can be particularly observed 
in central cells of the developing stalks (I, arrow) (E, F, G, I = parotid glands; H = mouth 
floor gland).  
(J, K, L, M, N) Caspase-7 expression; effector caspase-7 illustrated mixed nuclear and 
cytoplasmic expression during all glandular developmental stages (J-M), where nuclear 
pattern was more prominent at the pseudoglandular stage (J) while cytoplasmic positivity 
was stronger within more developed ducts at canalicular stage (L, M, arrowheads). High 
magnification illustrates nuclear caspase-7 within apoptotic cell of developing duct (N, 
arrow) (J, K, N = submandibular glands; L, M = mouth floor glands).  
(O, P, Q, R, S) Caspase-9 expression; similarly to caspase-6, caspase-9 demonstrated 
exclusive nuclear positivity at early stages (O, P) and localised cytoplasmic expression at 
later stages (Q, R, arrowheads). High power of developing duct shows nuclear (S, arrow) and 
cytoplasmic (S, arrowhead) caspase-9 in developing ductal region at later stage (S, arrow) 
(O, P, Q = submandibular glands; R = mouth floor gland; S = parotid gland). Arrows 
represent nuclear positivity, arrowheads indicate cytoplasmic expression. Magnifications: A-
H, J-M, O-R = 400X; I, N, S = 1260X (zoom). Scale bars = 30µm. 
 
Figure 4: The apoptosome complex is activated during human SG development and 
nuclear anti-apoptotic survivin is more prominent at later stages 
(A, B, C, D, E) Apaf-1 expression; nuclear detection was more prominent during initial 
stages (A, B, C, arrow) and at later stages the intercalated ducts showed important 
cytoplasmic expression while striated ducts remained mainly nuclear (C, D, arrowheads). 
High power shows mixed nuclear and cytoplasmic expression in developing duct (E, arrow 
and arrowhead) (A, B, C, E = submandibular glands; D = mouth floor gland).  
(F, G, H, I, J) Cytochrome c expression; exclusive cytoplasmic positivity was observed for 
cytochrome c protein during all developmental stages (F, I, J = mouth floor glands; G, H = 
parotid glands).  
(K, L, M, N, O) Survivin expression; cytoplasmic pattern was more prevalent at initial stages 
(K, L), becoming nearly absent at later stages (M, N). High power of developing duct shows 
nuclear survivin in ductal region (O, arrow) and cytoplasmic expression in acinar structure 
(O, arrowhead) (K, L, M, O = parotid glands; N = mouth floor gland). Arrows represent 
nuclear positivity, arrowheads indicate cytoplasmic expression. Magnifications: A-D, F-I, K-
N = 400X; E, J, O = 1260X (zoom). Scale bars = 30µm. 
 
Figure 5: Maintenance of the expression of apoptotic proteins in excretory ducts of 
human major SG 
 
(A, B, C, D) Expression of Bcl-2 family proteins in excretory ducts of submandibular gland at 
gestational age 20 weeks. Pro-apoptotic Bax was predominantly cytoplasmic (A, arrowhead) 
with focal nuclear expression (A, arrow), while Bak was only observed in the cytoplasm of 
basal cells (B, arrowhead). Anti-apoptotic markers Bcl-x and Bcl-xL were both detected in 
the cytoplasm and nuclei in ductal cells. Bcl-x was however more prominent within the 
cytoplasm (C, arrowhead) compared to the nuclear region (C, arrow), while Bcl-xL was 
mostly nuclear found mainly within the luminal layer (D).  
(E, F, G) Expression of caspases-6, -7 and -9 of submandibular gland at gestational age 20 
weeks. The expression of all caspases was more prominent in the nuclei of ductal cells, being 
caspase-7 exclusively found in the nuclei (F, arow). Caspases-6 and -9 also exhibited weak 
cytoplasmic expression in few ductal cells (E, G).  
(H, I, J) Mixed expression pattern of Apaf-1, Cytochrome c and survivin in excretory ducts 
of parotid (I) and submandibular glands (H, J) at gestational age 20 weeks. Apaf-1 was 
positive in both nuclei and cytoplasm (H), being more nuclear concentrated within luminal 
cells (H, arrow). Cytochrome c and survivin showed opposite expressions, where Cytochrome 
c was exclusively cytoplasmic (I) while survivin was only observed in nuclei (J). Arrows 
represent nuclear positivity and arrowheads indicate cytoplasmic expression. Magnification = 
400X. Scale bars = 30µm. 
 





